| http://www.w3.org/ns/prov#value | - Monitor liver function before and during therapy, especially in patients with underlying hepatic disease, including hepatitis B and hepatitis C, or marked transaminase elevations. (5.4, 8.6) PR interval prolongation may occur in some patients.
|
